Pharmacogenetics of breast cancer treatments: a sub-Saharan Africa perspective
KC Nthontho, AK Ndlovu, K Sharma… - Pharmacogenomics …, 2022 - Taylor & Francis
Breast cancer is the most frequent cause of cancer death in low-and middle-income
countries, in particular among sub-Saharan African women, where response to available …
countries, in particular among sub-Saharan African women, where response to available …
No Association between ABCB1 G2677T/A or C3435T Polymorphisms and Survival of Breast Cancer Patients—A 10-Year Follow-Up Study in the Polish Population
E Totoń, B Jacczak, W Barczak, P Jagielski, R Gryczka… - Genes, 2022 - mdpi.com
Many intensive studies are devoted to identifying novel cancer diagnostics or therapy
strategies that would boost cancer therapy efficacy and recovery rates. Importantly …
strategies that would boost cancer therapy efficacy and recovery rates. Importantly …
[PDF][PDF] In Silico Approach to Predict Indian Pharma-cogenomics Variants Based on Analysis of Linkage Dise-quilibrium (LD) and Expression Quantitative Trait Locus …
P Kumar - J Clin Med Img, 2023 - clinandmedimages.org
The drug response can vary based on ethnicity as it arises from differences in genetic
makeup among the individuals and is associated with drug action, metabolism and action …
makeup among the individuals and is associated with drug action, metabolism and action …